Thirty-nine hospitals across the United Kingdom are participating in a clinical trial investigating whether breast cancer radiotherapy can be shortened from three weeks to just five days.
The trial, known as FAST-Forward Boost, is examining whether a shorter radiotherapy schedule, combined with an additional targeted radiation dose called a boost, can effectively prevent breast cancer from returning.
More than 1,000 participants have already enrolled in the study, which is led by the Institute of Cancer Research in London and funded by the National Institute for Health and Care Research.
According to the UK Department of Health and Social Care on Friday, the proposed treatment approach could reduce the number of hospital visits required by patients by 10 if the trial proves successful.
The participating hospitals are:
-
The Royal Marsden Hospital, London
-
The Royal Marsden Hospital, Sutton
-
Addenbrooke’s Hospital, Cambridge
-
Christie Hospital, Manchester
-
Royal Surrey County Hospital
-
Churchill Hospital, Oxford
-
Singleton Hospital, Swansea
-
Royal Free Hospital, London
-
James Cook University Hospital, Middlesbrough
-
Royal Berkshire Hospital
-
Charing Cross Hospital, London
-
Southampton General Hospital
-
Western General Hospital, Edinburgh
-
St John’s Hospital, Livingston
-
Barts (St Bartholomew’s Hospital), London
-
Beatson West of Scotland Cancer Centre
-
Royal Alexandra Hospital, Paisley
-
Clatterbridge Cancer Centre
-
Queen Alexandra Hospital, Portsmouth
-
University Hospitals Coventry and Warwickshire
-
Weston Park Hospital, Sheffield
-
Royal Shrewsbury Hospital
-
Belfast City Hospital
-
Peterborough City Hospital
-
Northampton General Hospital
-
Dumfries and Galloway Royal Infirmary
-
Queen Elizabeth Hospital, Birmingham
-
Borders General Hospital
-
University Hospital Crosshouse, Kilmarnock
-
West Middlesex University Hospital
-
University Hospital Hairmyres
-
St James’s University Hospital, Leeds
-
Guy’s Hospital, London
-
Bristol Haematology and Oncology Centre
-
Ipswich Hospital
-
Forth Valley Royal Hospital
-
University College Hospital, London
-
Ealing Hospital
-
Mount Vernon Cancer Centre
The trial is targeting 4,830 participants by 2028. Those enrolled will be monitored for five years, with findings expected to be released in 2033.
We do everything possible to supply quality news and information to all our valuable readers day in, day out and we are committed to keep doing this.
Your kind donation will help our continuous research efforts.




















